The Journal of Allergy and Clinical Immunology
Volume 114, Issue 6 , Pages 1456-1462 , December 2004

Nuclear factor κB essential modulator–deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia

  • Tim Niehues, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • These two authors contributed equally to this work.
    • Corresponding Author InformationReprint requests: Tim Niehues, MD, Pediatric Immunology and Rheumatology Unit, Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine Universität Düsseldorf, Moorenstr 5, 40225 Düsseldorf, Germany.
    • ,
  • Janine Reichenbach, MD

      Affiliations

    • Unite d'Immunologie et d′Hematologie Pediatriques, Laboratoire de Genetique Humaine des Maladies Infectieuses, Universite de Paris Rene Descartes-INSERM U550, Faculte de Medecine Necker-Enfants Malades, Paris
    • These two authors contributed equally to this work.
    • ,
  • Jennifer Neubert, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • ,
  • Sonja Gudowius, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • ,
  • Anne Puel, MD

      Affiliations

    • Unite d'Immunologie et d′Hematologie Pediatriques, Laboratoire de Genetique Humaine des Maladies Infectieuses, Universite de Paris Rene Descartes-INSERM U550, Faculte de Medecine Necker-Enfants Malades, Paris
    • ,
  • Gerd Horneff, MD

      Affiliations

    • Department of Pediatrics, Martin Luther University Halle-Wittenberg
    • ,
  • Elke Lainka, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • ,
  • Uta Dirksen, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • ,
  • Horst Schroten, MD

      Affiliations

    • From the Pediatric Immunology and Rheumatology Unit, Departments of Pediatric Oncology, Hematology, and Immunology, and General Pediatrics, Heinrich Heine Universität Duesseldorf
    • ,
  • Rainer Döffinger, MD

      Affiliations

    • Unite d'Immunologie et d′Hematologie Pediatriques, Laboratoire de Genetique Humaine des Maladies Infectieuses, Universite de Paris Rene Descartes-INSERM U550, Faculte de Medecine Necker-Enfants Malades, Paris
    • ,
  • Jean Laurent Casanova, MD

      Affiliations

    • Unite d'Immunologie et d′Hematologie Pediatriques, Laboratoire de Genetique Humaine des Maladies Infectieuses, Universite de Paris Rene Descartes-INSERM U550, Faculte de Medecine Necker-Enfants Malades, Paris
    • ,
  • Volker Wahn, MD

      Affiliations

    • Children's Hospital Schwedt/Oder

Received 24 July 2004 ,Revised 19 August 2004 ,Accepted 20 August 2004.

References 

  1. Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004;16:34–41
  2. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol. 2004;113:725–733
  3. Carrol ED, Gennery AR, Flood TJ, Spickett GP, Abinun M. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child. 2003;88:340–341
  4. Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405:466–472
  5. Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001;10:2171–2179
  6. Mansour S, Woffendin H, Mitton S, Jeffery I, Jakins T, Kenwrick S, et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet. 2001;99:172–177
  7. Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–1562
  8. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2:223–228
  9. Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27:277–285
  10. Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le Deist F, et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics. 2002;109:e97
  11. Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R, et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002;109:1501–1509
  12. Masse JF, Perusse R. Ectodermal dysplasia. Arch Dis Child. 1994;71:1–2
  13. Priolo M, Lagana C. Ectodermal dysplasias: a new clinical-genetic classification. J Med Genet. 2001;38:579–585
  14. Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, Ito S, et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol. 1997;27:2073–2079
  15. Soler P, Boussaud V, Moreau J, Bergeron A, Bonnette P, Hance AJ, et al. In situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas. Clin Exp Immunol. 1999;116:332–339
  16. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1deficiency. Nat Genet. 2003;33:388–391
  17. Gulino AV, Notarangelo LD. Hyper IgM syndromes. Curr Opin Rheumatol. 2003;15:422–429
  18. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Ann Rev Immunol. 2002;20:581–620
  19. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973–980
  20. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–393
  21. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992;120:216–222
  22. Niehues T, Ndagijimana J, Horneff G, Wahn V. CD28 expression in pediatric human immunodeficiency virus infection. Pediatr Res. 1998;44:265–268
  23. Niehues T, McCloskey TW, Ndagijimana J, Horneff G, Wahn V, Pahwa S. Apoptosis in T-lymphocyte subsets in human immunodeficiency virus-infected children measured immediately ex vivo and following in vitro activation. Clin Diagn Lab Immunol. 2001;8:74–78
  24. Wahn V, Yokota S, Meyer KL, Janssen JW, Hansen-Hagge TE, Knobloch C, et al. Expansion of a maternally derived monoclonal T cell population with CD3+/CD8+/T cell receptor-gamma/delta+ phenotype in a child with severe combined immunodeficiency. J Immunol. 1991;147:2934–2941
  25. Horneff G, Guse AH, Schulze-Koops H, Kalden JR, Burmester GR, Emmrich F. Human CD4 modulation in vivo induced by antibody treatment. Clin Immunol Immunopathol. 1993;66:80–90
  26. Orange J, Levy O, Brodeur S, Krzewski K, Roy R, Niemela K, et al. Human NF-kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol. 2004;114:650–656In press

PII: S0091-6749(04)02394-2

doi: 10.1016/j.jaci.2004.08.047

The Journal of Allergy and Clinical Immunology
Volume 114, Issue 6 , Pages 1456-1462 , December 2004

Article Tools

* Image Usage & Resolution